Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Irish Pharmaceutical Healthcare Association .
Filed returns
16
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Jan–Apr 2026 | Irish Pharmaceutical Healthcare Association | Health | European Parliament resolution on Urban Waste Water Treatment Directive (UWWTD). (Legislation) | 8 | On lobbying.ie |
| Sep–Dec 2024 | Irish Pharmaceutical Healthcare Association | Health | Proposed revision of EU General Pharmaceutical Legislation and Irish Government position on intellectual property rights. (Legislation) | 4 | On lobbying.ie |
| Sep–Dec 2024 | Irish Pharmaceutical Healthcare Association | Health | European Commission Urban Waste Water Treatment Directive (UWWTD), with particular attention to the polluter payers principal and proportional responsibility. (Legislation) | 8 | On lobbying.ie |
| Jan–Apr 2024 | Irish Pharmaceutical Healthcare Association | Health | Raise awareness about the European Commission's revision of the EU Pharmaceutical Strategy and IPHA's key asks for the next European Parliament mandate. (Legislation) | 10 | On lobbying.ie |
| Sep–Dec 2023 | Irish Pharmaceutical Healthcare Association | Health | European Commission's proposed revision of EU Pharma Legislation and related matters, with particular attention to intellectual property rights provisions. (Legislation) | 4 | On lobbying.ie |
| May–Aug 2023 | Irish Pharmaceutical Healthcare Association | Health | EU Pharmaceutical Strategy (Legislation) | 3 | On lobbying.ie |
| Jan–Apr 2023 | Irish Pharmaceutical Healthcare Association | Health | Revision of pharmaceutical legislation by European Commission. (Legislation) | 9 | On lobbying.ie |
| Sep–Dec 2022 | Irish Pharmaceutical Healthcare Association | Health | Discuss the industry's position on innovation in the context of the EU Pharmaceutical Strategy (Public policy or programme) | 6 | On lobbying.ie |
| May–Aug 2022 | Irish Pharmaceutical Healthcare Association | Health | EU Pharmaceutical Strategy (Public policy or programme) | 13 | On lobbying.ie |
| Jan–Apr 2022 | Irish Pharmaceutical Healthcare Association | Health | (i) EU Pharmaceutical Policy; (ii) EFPIA WAIT Indicator Survey - Access to new medicines; (iii) Access to Orphan Medicines; (iv) EU Pharmaceutical Strategy (Public policy or programme) | 5 | On lobbying.ie |
| Sep–Dec 2018 | Irish Pharmaceutical Healthcare Association | Health | EU Commission proposals to introduce an SPC waiver on pharmaceutical products (Public policy or programme) | 6 | On lobbying.ie |
| May–Aug 2018 | Irish Pharmaceutical Healthcare Association | Health | EU legislative proposal to introduce an SPC waiver on pharmaceutical products (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2018 | Irish Pharmaceutical Healthcare Association | Economic Development and Industry | Proposed EU legislation to introduce a waiver on Special Protection Certificates (SPCs) for pharmaceutical products (Legislation) | 7 | On lobbying.ie |
| Jan–Apr 2016 | Irish Pharmaceutical Healthcare Association | Health | European Commission Country Specific Recommendations (CSRs) on Ireland relating to expenditiure on prescription medicines (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2015 | Irish Pharmaceutical Healthcare Association | Health | European Commission Country Specific Recommendations (CSRs) on Ireland related to expenditure on prescription medicines (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2015 | Irish Pharmaceutical Healthcare Association | Health | IPHA policy priorities as set out in "Policy and Budgetary Perspectives 2015 - 2016" document (Public policy or programme) | 21 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 15 | 93.8% | |
| Economic Development and Industry | 1 | 6.2% |